Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Neurotoxicology. 2016 Dec 19;60:150–160. doi: 10.1016/j.neuro.2016.12.005

Table 1.

Evoked Properties.

Isoform Nav1.1 Nav1.6


Treatment DMSO (0.1%) Deltamethrin (10μM) DMSO (0.1%) Deltamethrin (10μM)
Peak Current Densitya(pA/pF) 105.9 ± 33.0 (9) 154.7 ± 32.4 (19) 56.1 ± 12.6 (10) 29.3 ± 4.4 (20)
Persistent Current Densityb(pA/pF) 6.8 ± 3.6 (4) 68.0 ± 12.2* (19) −0.4 ± 0.6 (6) 9.2 ± 2.4* (20)
Tail Current Densitya (pA/pF) 21.4 ± 6.3 (9) 118.6 ± 18.5* (14) 5.9 ± 1.5 (10) 25.1 ± 4.1* (20)
Activation (V1/2) −22.6 ± 2.7 (7) −27.2 ± 6.7 (12) −20.7 ± 1.3 (10) −23.8 ± 1.3 (17)
Activation Slope Factor (k) 2.9 ± 0.42 (7) 3.9 ± 0.60 (12) 3.6 ± 0.3 (10) 5.0 ± 0.3* (17)
Persistent Activation (V1/2) −22.8 ± 1.4 (4) −34.7 ± 1.1* (16) N/A −26.8 ± 1.4 (9)
Persistent Activation Slope Factor (k) 6.5 ± 0.9 (4) 2.8 ± 0.3* (16) N/A 4.7 ± 1.1 (9)
Inactivation (V1/2) −50.4 ± 5.0 (8) −53.9 ± 4.7 (13) −56.6 ± 0.8 (12) −64.5 ± 1.3* (15)
Inactivation Slope Factor (k) 5.9 ± 0.7 (8) 5.2 ± 0.4 (13) 5.9 ± 0.2(12) 5.8 ± 0.3 (15)

Data are presented as Mean ± SEM.

*

p< 0.05, n in parenthesis.

a

Peaks taken at −10mV.

b

Peaks taken at − 20 mV.